Published in Neuropsychopharmacology on September 17, 2008
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology (2010) 5.07
Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat Protoc (2012) 1.75
Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.73
The adaptive threat bias in anxiety: amygdala-dorsomedial prefrontal cortex coupling and aversive amplification. Neuroimage (2011) 1.52
Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice. Psychopharmacology (Berl) (2009) 1.44
Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology (2010) 1.00
How bad could it be? Alcohol dampens stress responses to threat of uncertain intensity. Psychol Sci (2013) 0.96
Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology (2011) 0.92
Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study. Biol Psychiatry (2011) 0.90
Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol (2009) 0.89
The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle. Neuropsychopharmacology (2015) 0.85
Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis? Neuropsychopharmacology (2012) 0.85
Serotonin, Amygdala and Fear: Assembling the Puzzle. Front Neural Circuits (2016) 0.83
Using the threat probability task to assess anxiety and fear during uncertain and certain threat. J Vis Exp (2014) 0.82
Serotonergic modulation of conditioned fear. Scientifica (Cairo) (2012) 0.80
A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women. Psychopharmacology (Berl) (2014) 0.78
Chronic fluoxetine dissociates contextual from auditory fear memory. Neurosci Lett (2016) 0.75
The Unpredictive Brain Under Threat: A Neurocomputational Account of Anxious Hypervigilance. Biol Psychiatry (2017) 0.75
Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence. J Stud Alcohol Drugs (2017) 0.75
Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci (1997) 2.90
Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry (2008) 2.51
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry (2004) 2.31
Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience (2004) 2.30
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry (2006) 2.30
Anxious responses to predictable and unpredictable aversive events. Behav Neurosci (2004) 2.25
Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) (2007) 2.18
Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology (2003) 2.14
Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A (1998) 1.97
Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct (2008) 1.97
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2005) 1.88
Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci (2006) 1.67
The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry (2006) 1.67
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry (2004) 1.59
Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev (2001) 1.50
Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci (2004) 1.44
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol (2003) 1.44
A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology (2006) 1.37
Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology (Berl) (2003) 1.28
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry (1993) 1.25
Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology (2006) 1.24
Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage (2004) 1.10
An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol (1987) 1.06
Dorsal hippocampal contributions to unimodal contextual conditioning. J Neurosci (2006) 0.96
Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol (1999) 0.91
Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology (Berl) (1988) 0.91
Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults. Biol Psychiatry (2004) 0.90
Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology (Berl) (1988) 0.88
The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology (2006) 0.87
The SSRI antidepressants: exploring their "other" possible properties. J Affect Disord (1998) 0.85
Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice. Eur J Pharmacol (2002) 0.84
Anxiety sensitivity and modulation of the serotonergic system in patients with PD. J Anxiety Disord (2004) 0.77
Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry (2010) 16.89
Defining clinical phenotypes of juvenile mania. Am J Psychiatry (2003) 5.49
The social re-orientation of adolescence: a neuroscience perspective on the process and its relation to psychopathology. Psychol Med (2005) 4.14
Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry (2010) 3.96
Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther (2005) 3.83
Developing constructs for psychopathology research: research domain criteria. J Abnorm Psychol (2010) 3.79
Amygdala and nucleus accumbens in responses to receipt and omission of gains in adults and adolescents. Neuroimage (2005) 3.76
Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders. Am J Psychiatry (2008) 3.69
Triadic model of the neurobiology of motivated behavior in adolescence. Psychol Med (2006) 3.62
Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biol Psychiatry (2006) 3.59
Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry (2008) 3.22
Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry (2007) 3.10
Adolescent immaturity in attention-related brain engagement to emotional facial expressions. Neuroimage (2003) 2.98
Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90
Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry (2006) 2.90
Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am (2009) 2.89
Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. Am J Psychiatry (2007) 2.83
Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry (2009) 2.77
Depression in adolescence. Lancet (2012) 2.74
Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. Am J Psychiatry (2009) 2.72
Stable early maternal report of behavioral inhibition predicts lifetime social anxiety disorder in adolescence. J Am Acad Child Adolesc Psychiatry (2009) 2.69
Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proc Natl Acad Sci U S A (2006) 2.65
Choice selection and reward anticipation: an fMRI study. Neuropsychologia (2004) 2.52
Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry (2008) 2.51
Neural substrates of choice selection in adults and adolescents: development of the ventrolateral prefrontal and anterior cingulate cortices. Neuropsychologia (2006) 2.44
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
Amygdala and ventrolateral prefrontal cortex function during anticipated peer evaluation in pediatric social anxiety. Arch Gen Psychiatry (2008) 2.37
Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry (2007) 2.34
Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am J Psychiatry (2009) 2.33
Conflict of interest. Am J Psychiatry (2006) 2.30
Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation. Am J Psychiatry (2007) 2.25
Conduct disorder and callous-unemotional traits in youth. N Engl J Med (2014) 2.24
Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry (2007) 2.19
A developmental examination of amygdala response to facial expressions. J Cogn Neurosci (2008) 2.16
Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry (2009) 2.12
Attention bias modification treatment for pediatric anxiety disorders: a randomized controlled trial. Am J Psychiatry (2012) 2.11
Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations. J Child Adolesc Psychopharmacol (2006) 2.07
Striatal functional alteration in adolescents characterized by early childhood behavioral inhibition. J Neurosci (2006) 2.07
Abnormal ventromedial prefrontal cortex function in children with psychopathic traits during reversal learning. Arch Gen Psychiatry (2008) 2.06
Attention alters neural responses to evocative faces in behaviorally inhibited adolescents. Neuroimage (2007) 2.00
Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders. Am J Psychiatry (2008) 1.99
Effects of a psychosocial family-based preventive intervention on cortisol response to a social challenge in preschoolers at high risk for antisocial behavior. Arch Gen Psychiatry (2007) 1.97
Specificity of facial expression labeling deficits in childhood psychopathology. J Child Psychol Psychiatry (2007) 1.95
A dimensional approach to developmental psychopathology. Int J Methods Psychiatr Res (2007) 1.94
Disrupted expected value and prediction error signaling in youths with disruptive behavior disorders during a passive avoidance task. Am J Psychiatry (2013) 1.89
Generalization of conditioned fear-potentiated startle in humans: experimental validation and clinical relevance. Behav Res Ther (2008) 1.84
Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder. Am J Psychiatry (2007) 1.84
Probing the neural correlates of anticipated peer evaluation in adolescence. Child Dev (2009) 1.82
A history of childhood behavioral inhibition and enhanced response monitoring in adolescence are linked to clinical anxiety. Biol Psychiatry (2008) 1.81
Linear mixed-effects modeling approach to FMRI group analysis. Neuroimage (2013) 1.80
Attention biases to threat and behavioral inhibition in early childhood shape adolescent social withdrawal. Emotion (2010) 1.73
Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther (2008) 1.73
Contextual fear conditioning in humans: cortical-hippocampal and amygdala contributions. J Neurosci (2008) 1.72
Attention biases to threat link behavioral inhibition to social withdrawal over time in very young children. J Abnorm Child Psychol (2011) 1.72
Neural mechanisms of frustration in chronically irritable children. Am J Psychiatry (2013) 1.70
What is an anxiety disorder? Depress Anxiety (2009) 1.70
Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry (2009) 1.69
Patterns of neural connectivity during an attention bias task moderate associations between early childhood temperament and internalizing symptoms in young adulthood. Biol Psychiatry (2013) 1.68
Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: An FMRI study. Biol Psychiatry (2006) 1.68
The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry (2006) 1.67
Attention bias toward threat in pediatric anxiety disorders. J Am Acad Child Adolesc Psychiatry (2008) 1.64
Neural correlates of reward processing in adolescents with a history of inhibited temperament. Psychol Sci (2009) 1.63
Deficits in social cognition and response flexibility in pediatric bipolar disorder. Am J Psychiatry (2005) 1.62
Disrupted reinforcement signaling in the orbitofrontal cortex and caudate in youths with conduct disorder or oppositional defiant disorder and a high level of psychopathic traits. Am J Psychiatry (2010) 1.57
Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study. Arch Gen Psychiatry (2005) 1.57
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage (2005) 1.57
Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berl) (2010) 1.55
Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior. Am J Psychiatry (2014) 1.54
Facial emotion labeling deficits in children and adolescents at risk for bipolar disorder. Am J Psychiatry (2008) 1.54
Social norm processing in adult social phobia: atypically increased ventromedial frontal cortex responsiveness to unintentional (embarrassing) transgressions. Am J Psychiatry (2010) 1.51
Cognitive flexibility in phenotypes of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.50
Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry (2010) 1.49
Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry (2009) 1.47
Social anxiety disorder: questions and answers for the DSM-V. Depress Anxiety (2010) 1.46
Evidence for a gene-environment interaction in predicting behavioral inhibition in middle childhood. Psychol Sci (2005) 1.46
A developmental examination of gender differences in brain engagement during evaluation of threat. Biol Psychiatry (2004) 1.45
Conflict of interest, round 2. Am J Psychiatry (2006) 1.44
Neural response to self- and other referential praise and criticism in generalized social phobia. Arch Gen Psychiatry (2008) 1.40
Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry (2010) 1.39
Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task. Biol Psychiatry (2005) 1.39
Neuropsychological performance in pediatric bipolar disorder. Biol Psychiatry (2004) 1.38
A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology (2006) 1.37
Attention biases, anxiety, and development: toward or away from threats or rewards? Depress Anxiety (2011) 1.37
Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation. Biol Psychiatry (2005) 1.37
Irritability in pediatric mania and other childhood psychopathology. Ann N Y Acad Sci (2003) 1.36
The NIMH Child Emotional Faces Picture Set (NIMH-ChEFS): a new set of children's facial emotion stimuli. Int J Methods Psychiatr Res (2011) 1.35
Attentional bias for emotional faces in children with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.35
Autism spectrum traits in children with mood and anxiety disorders. J Child Adolesc Psychopharmacol (2005) 1.35
Relationship between trait anxiety, prefrontal cortex, and attention bias to angry faces in children and adolescents. Biol Psychol (2008) 1.34
The strong situation: a potential impediment to studying the psychobiology and pharmacology of anxiety disorders. Biol Psychol (2005) 1.33
Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J Am Acad Child Adolesc Psychiatry (2009) 1.32
Striatal functional alteration during incentive anticipation in pediatric anxiety disorders. Am J Psychiatry (2012) 1.32
Neural connectivity in children with bipolar disorder: impairment in the face emotion processing circuit. J Child Psychol Psychiatry (2008) 1.32
Development of anxiety: the role of threat appraisal and fear learning. Depress Anxiety (2010) 1.31
Early-life stress is associated with impairment in cognitive control in adolescence: an fMRI study. Neuropsychologia (2010) 1.30
fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) (2006) 1.30
Elucidating early mechanisms of developmental psychopathology: the case of prenatal smoking and disruptive behavior. Child Dev (2006) 1.29
Facial expression recognition in adolescents with mood and anxiety disorders. Am J Psychiatry (2003) 1.27
Developmental differences in neuronal engagement during implicit encoding of emotional faces: an event-related fMRI study. J Child Psychol Psychiatry (2003) 1.27
Researching the pathophysiology of pediatric bipolar disorder. Biol Psychiatry (2003) 1.27